Cite
HARVARD Citation
Parkin, L. et al. (2022). Authors reply: Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50%. Journal of internal medicine. pp. 707-708. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Parkin, L. et al. (2022). Authors reply: Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50%. Journal of internal medicine. pp. 707-708. [Online].